Compare Stocks

A SPAC I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Singapore.

A SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech primarily in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corp. is a subsidiary of A SPAC II (Holdings) Corp.

Aberdeen Standard Global Infrastructure Income Fund seeks to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society. The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments from around the world.

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company's first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs t